Answer
Insulin degludec (Tresiba) has a half-life of approximately 25 hours after subcutaneous administration, independent of dose and determined by its absorption rate from subcutaneous tissue.
Sources for this answer
- Tresiba 100 units/mL PenfillNovo Nordisk Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 2Document updated
Sources checked